Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evert Sanders

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Health and Quality of Life Outcomes|November 17, 2010
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre studyPeter J Jongen, Dirk Lehnick, Evert Sanders, et al.
Patient Preference and Adherence|April 17, 2013
Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatmentPeter Joseph Jongen, Evert Sanders, Cees Zwanikken, et al.
Plos One|November 3, 2011
Adverse events of interferon beta-1a: a prospective multi-centre international ICH-GCP-based CRO-supported external validation study in daily practicePeter Joseph Jongen, Christian Sindic, Evert Sanders, et al.
BMC Neurology|June 9, 2011
Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive batteryChris Edgar, Peter J Jongen, Evert Sanders, et al.
Plos One|May 3, 2014
Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosisPeter Joseph Jongen, Keith Wesnes, Björn van Geel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Health and Quality of Life Outcomes|November 17, 2010
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre studyPeter J Jongen, Dirk Lehnick, Evert Sanders, et al.
Patient Preference and Adherence|April 17, 2013
Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatmentPeter Joseph Jongen, Evert Sanders, Cees Zwanikken, et al.
Plos One|November 3, 2011
Adverse events of interferon beta-1a: a prospective multi-centre international ICH-GCP-based CRO-supported external validation study in daily practicePeter Joseph Jongen, Christian Sindic, Evert Sanders, et al.
BMC Neurology|June 9, 2011
Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive batteryChris Edgar, Peter J Jongen, Evert Sanders, et al.
Plos One|May 3, 2014
Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosisPeter Joseph Jongen, Keith Wesnes, Björn van Geel, et al.
Pageof 1